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Methods: 1091 patients with suspected ischemic chest pain underwent a clinically
indicated angiography and enrolled in this study. Signiﬁcant CAD was deﬁned as
50% stenosis in any one major epicardial coronary artery. Multivariate logistic
regression was used to determine predictors of signiﬁcant CAD.
Results:More women than men were found with normal/non-signiﬁcant CAD (44.3%
vs. 29.5%), but more men were shown either left-main or three-vessel disease (25.5%
vs. 14.2%). Among patients with signiﬁcant CAD, more women had relatively mild
coronary artery lesions (50-74% stenosis) (27.5% vs. 16.5%), more men had the most
severity CAD (90-100% stenosis) (65.3% vs. 56.5%). Risk factors independently
associated with signiﬁcant CAD including age, hypertension, diabetes mellitus, and
prior myocardial infarction for both genders, LDL-C (>100 mg/dl) was separately for
men, and postmenopause was separately for women.
Conclusions:Women referred for angiography are more likely to have normal or non-
signiﬁcant CAD and lower rates of signiﬁcant CAD compared with men across all
ages. Predictors of signiﬁcant CAD of Chinese population were similar with Western
population. It was a fortunate result because measures of CAD primary prevention
used in Western countries may be also suitable for China.
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The Impact of Epicardial Fat Volume and Inﬂammatory Cytokines on Coronary
Artery Disease and Atherosclerotic Plaque Stability
Dong Chen, Jing Wang
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Objectives: Epicardial fat is an unusual visceral adipose tissue that is functionally
and anatomically related to the coronary arteries and has been reported to be a rich
source of various cytokines. Several groups have demonstrated that both epicardial
fat and adipokines derived from adipose tissue may directly affect the progression of
atherosclerosis. A previous study by our group has indicated that epicardial fat
volume (EFV) is an independent predictor of the presence and severity of coronary
atherosclerosis; however, the relationships between EFV, cytokine levels, and
coronary plaque vulnerability have not been studied extensively. This study aimed
to investigate the impact of EFV and cytokines in plasma on coronary plaque
stability.
Methods: Patients who were undergoing coronary angiography and dual-source CT
were enrolled in the study from February to October 2013. EFV, spot plaque,
remodeling index, and low-density plaque were calculated from CT scans using
software provided by Siemens Medical Solutions. Fasting blood samples were
collected for biochemical examination and cytokine quantitation by ELISA. Statistical
analyses were performed using SPSS 19.0.
Results: (1) Compared with those of the non-CAD group, the low-density lipo-
protein cholesterol (LDL-C), body mass index (BMI) and EFV of CAD group were
signiﬁcantly higher, while high-density lipoprotein cholesterol (HDL-C) demon-
strated the opposite trend (P<0.05). (2) Compared with those of the non-CAD
group, the levels of plasma tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-
6) were higher in CAD group, while plasma adiponectin levels were signiﬁcantly
lower (P<0.05). (3) The levels of plasma matrix metallopeptidase-9 (MMP-9),
pregnancy associated plasma protein-A (PAPP-A), and leptin in the vulnerable
plaque group were signiﬁcantly higher than those of the stable plaque group, while
C1q/TNF-related protein-9 (CTRP-9) levels were lower (P<0.05). (4) EFVs in the
CAD group were higher than those of the non-CAD, and EFVs in the vulnerable
plaque group were higher than those of the stable plaque group (P<0.05). (5) EFVs
were positively correlated with plasma TNF-a, IL-6, soluble P-selectin (sP-selec-
tin), MMP-9, PAPP-A, and leptin levels, and adiponectin and CTRP-9 were
demonstrated negative correlations (P<0.05); however, when normalized to BMI,
the correlation between EFV and TNF-a, IL-6, and sP-selectin levels weakened
(P>0.05).
Conclusions: EFV and the levels of plasma TNF-a, IL-6, MMP-9, PAPP-A, and
leptin are associated with CAD and the stability of plaque, while plasma adiponectin
and CTRP-9 have found to confer protection against CAD and plaque. EFVs were
positively correlated with plasma MMP-9, PAPP-A, and leptin, while plasma CTRP-9
and adiponectin exhibited negative correlations. Both EFV and plasma inﬂammatory
cytokine levels were shown to effect CAD severity and plaque stability.
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Clinical value of cardiac hybrid SPECT/CTA imaging on management strategies
in CAD
Dong Wei, Wang Qian
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Objectives: Cardiac hybrid imaging helps improve the diagnostic accuracy of coro-
nary artery disease (CAD) and provides important, comprehensive information
necessary for timely and appropriate treatment. We aimed at assessing the potential
value of cardiac hybrid imaging on the selection of appropriate management strategy
for CAD.
Methods: 238 patients underwent two day stress/rest 99mTc-MIBI single-photo
emission computed tomography (SPECT) and coronary computed tomography
angiography (CCTA) on a separate scanner for CAD evaluation prior to treatment.
Patients were divided into 3 groups according to the ﬁndings by hybrid SPECT and
CCTA: (1) both CCTA and SPECT results were abnormal, meanwhile the stenosesJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cfound by CCTA and the ischemic myocardium found by SPECT matched well; (2)
SPECT and CCTA ﬁndings did not match; and (3) both SPECT and CCTA results
were normal. According to the hybrid imaging results, 4 types of treatment decisions
were made listed as following: (1) no therapy; (2) optimal medical treatment (OMT);
(3) percutaneous coronary intervention (PCI); and (4) coronary artery bypass
grafting (CABG). Follow-up was performed during the ﬁrst 60 days after hybrid
imaging.
Results: Hybrid images revealed matched, unmatched, and normal ﬁndings in
66, 106, and 66 patients. The Invasive Coronary Angiography (ICA) rate within
60 days was 64% (42/66), 9% (10/106) and 0% (0/66) for matched, unmatched
and normal ﬁndings, respectively. And revascularization rate was 51.5% (34/66),
0% (0/106) and 0% (0/66) for matched, unmatched and normal ﬁndings,
respectively.
Conclusions: The incremental value of hybrid cardiac imaging resides in the accurate
spatial co-localization of myocardial perfusion defects and subtending coronary ar-
teries. So it may facilitate the identiﬁcation of haemodynamically signiﬁcant coronary
artery stenoses and thereby guide clinicians on the appropriate treatment strategy for
CAD.
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Blood neopterin and endothelin levels in patients with coronary heart disease
Zhu Zhijun, Wu Danning
the 117th Hospital of PLA
Objectives: To investigate the serum neopterin and endothelin levels in patients with
coronary heart disease (CHD), to implore the probable mechanism of immune and
endothelium function in CHD.
Methods: The levels of neopterin and endothelin in 56 persons who were divided into
two group, (control group, n¼16) and (patient group, n¼40) conﬁrmed by coronary
angiography, were measured. The relationship between the levels of neopterin,
endothelin and the number of narrow artery in coronary heart disease patients was
analyzed.
Results: The levels of neopterin in patients was higher than that in control group
(respectively 15.167.44 nmol/L and 8.384.69 nmol/L, P<0.01). It got more higher
with the number of diseased coronary artery in patients got more (r¼ 0.378 P< 0.05).
The levels of endothelin in patients was higher than that in control group (respectively
93.4127.33 mg/L and 67.5820.04 mg/L, P<0.01). But it got not higher with the
number of diseased coronary artery in patients got more (r¼ 0.298, P> 0.05). The
levels of neopterin got much higher with the levels of endothelin increased. There was
a positive relationship between neopterin and endothelin levels in the patients (r¼
0.350, P <0.05).
Conclusions: Neopterin and immune may take part in the pathophysiological process
of CHD and they also affect the endothelium function.GW25-e4543
The relationship of thyroid function and the severity of coronary artery in
patients with coronary artery disease
Xue Chao, Bian Ling
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Objectives: To evaluate thyroid function in hospitalized patients with coronary heart
condition (CAD) and to explore and the relationship between free thyroxine (FT3)
level and the severity of coronary artery stenosis in CAD patients.
Methods: A total of 238 CAD patients who were admitted into our hospital during
2012 to 2014 were selected to perform serum thyroxine levels. The ﬁrst purpose was
to explore the thyroid function in patients with coronary heart disease. Then patients
with hyperthyroidism, hypothyroidism, subclinical hyperthyroidism and subclinical
hypothyroidism were excluded, the remaining patients were divided into normal FT3
group and low FT3 group according to FT3 levels. The second purpose was to
compare the general clinical condition and the severity of coronary artery in the two
groups of patients.
Results: (1) Among 238 CAD patients, 2 cases with hyperthyroidism (0.84%), 11
cases with hypothyroidism (4.62%), 3 cases with subclinical hyperthyroidism
(1.26%), 5 cases with subclinical hypothyroidism (2.10%), and 25 cases with low T3
syndrome (10.50%). Low T3 syndrome is most common thyroid dysfunction in pa-
tients with CAD. (2) Patients with low FT3 had higher level of total cholesterol (TC)
and apolipoprotein E (ApoE) than normal FT3 group (P0.005), meanwhile they also
had higher level of creatinine (P¼0.007) and NT-proBNP (P<0.001) than normal FT3
group. (3) Low FT3 patients had higher proportion of three-vessel disease than normal
FT3 group (P <0.001).
Conclusions: The low T3 syndrome is most common thyroid dysfunction in patients
with coronary heart disease, and patients with low FT3 are more likely to multi-vessel
involvement.
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The relationship between serum TNF-a and sICAM levels and the severity of
coronary artery diseases
Zhang Xingtong, Huang Dayang, Wang Miao, Zhao Juan
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Objectives: To identify the role of tumor necrosis factor-a (TNF-a) and soluble
intercellular adhesion molecule (sICAM) in the process of coronary artery diseases
and assess the correlation between TNF-a and sICAM levels and the severity of
coronary artery diseases (CAD).
Methods: The serum concentration of TNF-a and sICAM were measured in pe-
ripheral blood (venae radiales) of 30 patients with acute myocardial infarction
(AMI),30 with stable angina pectoris (AP),and 30 control cases (Con) who were
healthy subjects. For patients with AMI, the blood samples were obtained in 24 hours
after acute myocardial infarction. For patients with AP, the blood samples were ob-
tained in 24 hours after the latest angina pectoris. All the blood samples were obtained
in the fasting state. The serum concentration of TNF-a and sICAM were measured by
enzyme linked immunosorbent assay. The general data were recorded, such as gender,
age, history of disease, and smoking. One-way ANOVA and Pearson correlation
coefﬁcient were used to analyze the results.
Results: There was no signiﬁcant difference in gender, age, history of disease, and
smoking among the three groups (P>0.05).The TC, TG, LDL levels of AMI and
AP groups were signiﬁcantly higher than the Con group (P<0.05), but there was
no signiﬁcant difference between AMI and AP group (P>0.05). The serum con-
centrations of TNF-a and sICAM (ug/l) in patients with AMI were higher than the
AP and the Con subjects (P<0.01).And the AP group was higher than the Con
group (P<0.01). (TNF-a: AMI 0.460.44, AP 0.0760.023, Con 0.0590.012,
sICAM: AMI 1.370.44, AP 0.750.25, Con 0.470.23) (P<0.01). In the three
groups, the levels of TNF-a and sICAM were positively correlated (r¼0.634,
P<0.01).
Conclusions: TNF-a and sICAM were involved in the process of coronary artery
diseases. They were positively correlated with the severity of CAD.
GW25-e5396
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Objectives: Macrophage migration inhibitory factor (MIF) has been implicated in the
pathogenesis of coronary artery disease (CHD). We explored the plasma MIF level
and studied its predictive value of major adverse cardiac events in CHD patients.
Methods: There were 126 patients with acute myocardial infaction (AMI), 154 pa-
tients with unstable angina (UA), 40 patients with stable angina (SA) who were
recruited from First Afﬁliate Hospital of Xi’an Jiaotong University from January 2012
to December 2013. At the same time, 116 control patients with coronary adiography
negative and without heart disease history were selected. The next day morning,
fasting venous blood were collected. Plasma MIF levels were measured by ELISA. All
patients were followed up for a period of around 1 year. The endpoint events were
deﬁned as major adverse cardiac events (MACE), including cardiac death, non-fatal
myocardial infarction and target vessel revascularization (TVR).
Results: The plasma MIF levels were signiﬁcantly higher in CHD than in control
patients (11.12 (6.81, 11.86) vs. 4.42 (3.15, 6.50) ng/ml. Meanwhile, plasma
MIF levels were much higher in AMI than UA (17.51 (13.28, 26.90) vs. 7.80
(5.41, 11.66) ng/ml, P<0.01) and SA patients (17.51 (13.28,26.90) vs. 7.68
(4.60,10.98) ng/ml, P<0.01). During the period of follow up, 17 patients with AMI
or UA who had lower MIF level experienced endpoint events. Multivariate logistic
regression analysis revealed that the increment of MIF levels (per 10 ng/ml MIF)
resulted in a markedly reduced risk for MACE (OR¼0.78, 95% CI 0.61-1.04)
in AMI patients. Kaplan-Meier plots for MACE-free survivals showed a signiﬁcant
difference between higher and lower MIF levels in AMI patients
(Logrank¼23.751, P<0.01). Corrected by traditional cardiovascular risk factors,
circulating MIF in acute stage still played a notable protective effect in AMI pa-
tients (HR¼0.78, 95% CI 0.61-1.04). The c-statistic showed that the predictive
value of MIF level was incremental over that of the conventional predictors for
coronary events in AMI group.
Conclusions: Plasma MIF levels are signiﬁcant higher in CHD group, especially in
AMI patients. AMI patients with much higher MIF level in acute stage have fewer
MACE events than those patients who have lower MIF level. Acute stage MIF level
can be an independent prognostic predictive factor for AMI patients.
Funding: This work was supported by the National Basic Research Program of
China (“973 Project” No. 2012CB517804).
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Effects of impaired glucose metabolism on heart rate variability in patients with
coronary atherosclerotic heart disease
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Objectives: The effects of impaired glucose metabolism (IGM) on heart rate vari-
ability (HRV) in patients with coronary atherosclerotic heart disease have been lessC122 JACC Vol 64/16/Suppl C j October 16–1studied. The study aimed to compare the heart rate, HRV and the circadian variation of
heart rate among the patients with combined coronary atherosclerotic heart disease and
impaired glucose metabolism, the patients with coronary atherosclerotic heart disease,
and the normal control; to investigate the relation between different levels of HbA1c
and the parameters of HRV in coronary atherosclerotic heart disease patients with
IGM.
Methods: The study population consisted of three groups: 129 patients with
combined angiographically documented coronary atherosclerotic heart disease and
IGM (Group CAD + IGM), 207 patients with angiographically documented coro-
nary atherosclerotic heart disease (Group CAD), and 76 normal subjects (Group
Control). We divided the group CAD + IGM into 2 subgroups according to the
levels of HbA1c (Group HbA1c7.0%, and Group HbA1c<7.0%). All subjects’
clinical data, fasting blood results, LVEF, and the features of coronary artery le-
sions by coronary angiography or coronary 320-slice CT were collected. All sub-
jects performed a 24-hour dynamic electrocardiogram monitoring. The 24-hour
means heart rate, time domain and frequency domain parameters of HRV were
collected.
Results: There was a signiﬁcant decline of 24-hour values of all HRV parameters in
group CAD + IGM vs group CAD and group Control, with the highest in controls, the
intermediate in group CAD, and the lowest value in group CAD + IGM. SDNN,
SDANN, SDNN-Index, RMSSD, PNN50 and TP, VLF, LF, HF were signiﬁcantly
different among these three groups (P<0.05). The mean heart rate of group CAD +
IGM, group CAD, and group Control showed a trend of gradually reducing. The mean
heart rate presented a marked day-night pattern in all three groups, with a decline in
nighttime and a increase in daytime. The variation trend among three groups had a
signiﬁcant difference (P<0.05).The 24-hour values of all HRV parameters between
the subgroup HbA1c7.0% and subgroup HbA1c<7.0% did not show signiﬁcant
differences.
Conclusions: Patients with coronary atherosclerotic heart disease present a cardiac
autonomic nervous dysfunction. Impaired glucose metabolism can make a further
exacerbation on the cardiac autonomic nervous dysfunction of these coronary
atherosclerotic heart disease patients. The mean heart rate present a marked day-night
pattern in all three groups, with a decline in nighttime and a increase in daytime. But
the nighttime heart rate in group Control decreases to a signiﬁcantly lower level than
those in the other two groups. The 24-hour values of all HRV parameters between the
subgroup HbA1c7.0% and subgroup HbA1c<7.0% do not show signiﬁcant
differences.
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Sex differences in risk factors in patients with acute coronary syndrome
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Objectives: To provide a theoretical basis for clinical prevention and treatment of
coronary heart disease in patients with different gender by analyzing the gender dif-
ferences in patients with risk factors of ACS.
Methods: The clinical data and angiographic results of 1269 ACS patients
were collected from March 2012 to January 2014, including 901 male patients and
368 female patients. The patients were grouped by age into middle-aged group
(age 55) and older-aged group (age>55), and grouped by blood lipid levels
into normal HDL - C group (0.91 mmol/L) and HDL - C lower group (< 0.91
mmol/L), while also divided into non-HDL-C<3.37 mmol/L group and non-
HDL-C3.37 mmol/L group. The traditional CHD risk factors (including age,
smoking, blood pressure, blood glucose, BMI, family history) and coronary
angiographic changes of these patients are analyzed and compared between
different genders.
Results: (1) The age of female ACS patients is 68.08.5 years old and that of the
male patients is 62.311.2 years old, so the women’s onset age of acute coronary
syndrome (ACS) is older than men’s. (2) The incidence of women with hyper-
tension and diabetes is higher than that of men, and the proportion of men with a
smoking history is signiﬁcantly higher than that of women (P<0.05). (3) According
to the division standard of Chinese adults’ Blood lipid control guide, the TC at the
appropriate level accounted for 73.9% of men, which accounted for 60.6% of
women. The TG at the appropriate level accounted for 56.9% of men, which
accounted for 45.9% of women. The LDL-C at the appropriate level accounted for
65.3% of men, which accounted for 57.6% of women. The HDL-C at the appro-
priate level accounted for 33.4% of men, which accounted for 55.6% of women.
(4). LDL-C/HDL-C of elder women is higher than that of middle-aged women.
HDL-C and Apo-a of elder men is higher than that of middle-aged men. (5) The
proportion of normal HDL-C both in the middle-aged and elder-aged group of
women is higher than that of men, and the proportion of men’s lower HDL-C level
is higher than that of women’s (P<0.05). There is no gender difference in corre-
lation between HDL-C and the severity of coronary artery lesions. (6) In age>55
patients, there have signiﬁcant gender differences between non-HDL-C<3.37
mmol/L and non-HDL-C3.37 mmol/L group. But in age55 patients, there has
no difference in correlation between non-HDL-C and the severity coronary artery
lesions.
Conclusions: (1) The ACS incidence of women in age55 is lower than that in the
same-aged men; however the ACS incidence of women in age>55 signiﬁcantly
increased, even higher than that in the same-aged men. (2) The effect of hypertension
and diabetes for women is larger than that for men, while the effect of smoking history
for men is larger than that for women. There is no gender difference between CHD9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
